Found: 28
Select item for more details and to access through your institution.
Peptide Receptor Radionuclide Therapy in Merkel Cell Carcinoma: A Comprehensive Review.
- Published in:
- Journal of Nuclear Medicine Technology, 2023, v. 51, n. 1, p. 22, doi. 10.2967/jnmt.122.264904
- By:
- Publication type:
- Article
Peptide Receptor Radionuclide Therapy in Merkel Cell Carcinoma: A Comprehensive Review.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Early injection of furosemide increases detection rate of local recurrence in prostate cancer patients with biochemical recurrence referred for 68Ga-PSMA-11 PET/CT.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.261866
- By:
- Publication type:
- Article
Early injection of furosemide increases detection rate of local recurrence in prostate cancer patients with biochemical recurrence referred for 68Ga-PSMA-11 PET/CT. ..
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.261866
- By:
- Publication type:
- Article
Early injection of furosemide increases detection rate of local recurrence in prostate cancer patients with biochemical recurrence referred for 68Ga-PSMA-11 PET/CT.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.261866
- By:
- Publication type:
- Article
Early injection of furosemide increases detection rate of local recurrence in prostate cancer patients with biochemical recurrence referred for 68Ga-PSMA-11 PET/CT.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.261866
- By:
- Publication type:
- Article
Early injection of furosemide increases detection rate of local recurrence in prostate cancer patients with biochemical recurrence referred for 68Ga-PSMA-11 PET/CT.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.261866
- By:
- Publication type:
- Article
Early injection of furosemide increases detection rate of local recurrence in prostate cancer patients with biochemical recurrence referred for 68Ga-PSMA-11 PET/CT.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.120.261866
- By:
- Publication type:
- Article
Early injection of furosemide increases detection rate of local recurrence in prostate cancer patients with biochemical recurrence referred for 68Ga-PSMA-11 PET/CT.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.261866
- By:
- Publication type:
- Article
Twelve-Year Follow-up After Peptide Receptor Radionuclide Therapy.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 4, p. 524, doi. 10.2967/jnumed.118.215376
- By:
- Publication type:
- Article
Quality of Life in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors Receiving Peptide Receptor Radionuclide Therapy: Information from a Monitoring Program in Clinical Routine.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 10, p. 1566, doi. 10.2967/jnumed.117.204834
- By:
- Publication type:
- Article
Comparison of Early Imaging and Imaging 60 min Post-Injection after Forced Diuresis with Furosemide in the Assessment of Local Recurrence in Prostate Cancer Patients with Biochemical Recurrence Referred for 68Ga-PSMA-11 PET/CT.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 7, p. 1191, doi. 10.3390/diagnostics11071191
- By:
- Publication type:
- Article
Impact of forced diuresis with furosemide and hydration on the halo artefact and intensity of tracer accumulation in the urinary bladder and kidneys on [68Ga]Ga-PSMA-11-PET/CT in the evaluation of prostate cancer patients.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 1, p. 123, doi. 10.1007/s00259-020-04846-3
- By:
- Publication type:
- Article
Visualization of malignant infiltration of the thoracic duct on 68Ga PSMA-11 PET/CT in a prostate cancer patient with biochemical recurrence.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 8, p. 2042, doi. 10.1007/s00259-019-04637-5
- By:
- Publication type:
- Article
Correction to: The 68Ga/177Lu-theragnostic concept in PSMA-targeting of metastatic castration–resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
The 68Ga/177Lu-theragnostic concept in PSMA-targeting of metastatic castration–resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 3, p. 695, doi. 10.1007/s00259-019-04583-2
- By:
- Publication type:
- Article
Comparison of [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT with [<sup>18</sup>F]NaF PET/CT in the evaluation of bone metastases in metastatic prostate cancer patients prior to radionuclide therapy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 11, p. 1873, doi. 10.1007/s00259-018-4048-6
- By:
- Publication type:
- Article
Early PET imaging with [68]Ga-PSMA-11 increases the detection rate of local recurrence in prostate cancer patients with biochemical recurrence.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 10, p. 1647, doi. 10.1007/s00259-017-3743-z
- By:
- Publication type:
- Article
Current knowledge on the sensitivity of the Ga-somatostatin receptor positron emission tomography and the SUV reference range for management of pancreatic neuroendocrine tumours.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2016, v. 43, n. 11, p. 2072, doi. 10.1007/s00259-016-3395-4
- By:
- Publication type:
- Article
Direct comparison of Ga-DOTA-TOC and F-FDG PET/CT in the follow-up of patients with neuroendocrine tumour treated with the first full peptide receptor radionuclide therapy cycle.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2016, v. 43, n. 9, p. 1585, doi. 10.1007/s00259-016-3328-2
- By:
- Publication type:
- Article
Multiparametric PET imaging in thyroid malignancy characterizing tumour heterogeneity: somatostatin receptors and glucose metabolism.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2015, v. 42, n. 13, p. 1995, doi. 10.1007/s00259-015-3114-6
- By:
- Publication type:
- Article
Persistent quality of life impairments in differentiated thyroid cancer patients: results from a monitoring programme.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2015, v. 42, n. 8, p. 1179, doi. 10.1007/s00259-015-3022-9
- By:
- Publication type:
- Article
Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2015, v. 42, n. 8, p. 1284, doi. 10.1007/s00259-015-3078-6
- By:
- Publication type:
- Article
Ga-PSMA ligand PET versus F-NaF PET: evaluation of response to Ra therapy in a prostate cancer patient.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2015, v. 42, n. 2, p. 362, doi. 10.1007/s00259-014-2922-4
- By:
- Publication type:
- Article
Ga-DOTATOC PET/CT provides accurate tumour extent in patients with extraadrenal paraganglioma compared to I-MIBG SPECT/CT.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2015, v. 42, n. 1, p. 33, doi. 10.1007/s00259-014-2892-6
- By:
- Publication type:
- Article
Long-Term Survival and Value of 18 F-FDG PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with Second Peptide Receptor Radionuclide Therapy Course with 177 Lu-DOTATATE.
- Published in:
- Life (2075-1729), 2021, v. 11, n. 3, p. 198, doi. 10.3390/life11030198
- By:
- Publication type:
- Article
Systematic review reveals lack of quality in reporting health-related quality of life in patients with gastroenteropancreatic neuroendocrine tumours.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Radiation exposure after <sup>177</sup>Lu-DOTATATE and <sup>177</sup>Lu-PSMA-617 therapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article